David Hui Li is Director at China Biologic Products, Inc. (CBPO). They have made 1 open-market trade across 1 company since 2015, most recently 2016-08-11.
CIK 0001484155
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CBPO | 269 | $32K |
Shares reported on the most recent Form 4, priced at the 2016-08-12 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CBPO | SELL | 2015-06-15 | 2015-06-17 | $100.28 | $265.2M | -15.1% | +2.2% | +2.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.